admin

Presented by: Will McBride Alex Muresianu Debate swirls around the transition to a greener economy. On October 1st, the European Union (EU) began implementing its carbon tariff, called the Carbon Border Adjustment Mechanism (CBAM). Starting in 2025, the policy will place a tax on certain carbon-intensive imports. CBAM is intended to put EU industry that
0 Comments
In this article F GM Follow your favorite stocksCREATE FREE ACCOUNT Jim Farley, CEO, Ford, left, and Mary Barra, CEO, General Motors Reuters; General Motors DETROIT — Ready for a tightrope walk? General Motors and Ford Motor report third-quarter earnings and future guidance this week amid ongoing strikes and contract negotiations with the United Auto
0 Comments
Despite a murky macroeconomic environment and heightened fears around the health of the banking sector, the nation’s largest financial institutions all reported earnings beats for the third quarter. Some businesses performed better than others. However, none of them has been rewarded with higher stock prices — yet. As expected, money center banks like Wells Fargo
0 Comments
CCCTB vs. BEFIT: EU Corporate Tax Base: Details & Analysis Skip to content Home • Blog • CCCTB vs. BEFIT: How Have the Proposals Changed? The European Union (EU) has tried to create a common corporate tax baseThe tax base is the total amount of income, property, assets, consumption, transactions, or other economic activity subject
0 Comments
Travelers are flocking to airport lounges in search of complimentary food, drinks and perhaps most importantly, a chance to relax away from the hordes of travelers at the gate. The problem: plenty of other travelers are too. Armed with high-end rewards credit cards and fresh from years of big spending, more and more travelers are
0 Comments
In this article Follow your favorite stocksCREATE FREE ACCOUNT Sanjeri | E+ | Getty Images Company: Fortrea Holdings (FTRE) Business: Fortrea Holdings is a global contract research organization, or CRO, that provides clinical development and patient access solutions to the life sciences industry. CROs work with drug companies through all stages of the drug development
0 Comments